Changes in hypothalamic neuropeptide Y and monoaminergic system in tumor-bearing rats: Pre- and post-tumor resection and at death

Surgery

Volumn 136, Issue 2, 2004, Pages 270-276

  Ramos, Eduardo J B ^a   Suzuki, Susumu ^a   Meguid, Michael M ^a   Laviano, Alessandro ^a   Sato, Tomoi ^a   Chen, Chung ^a   Das, Undurti ^a  

^a University Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; NEUROPEPTIDE Y; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOREXIA; ARTICLE; BODY FAT; BODY WEIGHT; CANCER MORTALITY; CANCER SURGERY; CONTROLLED STUDY; FOOD INTAKE; MALE; MONOAMINERGIC SYSTEM; NONHUMAN; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; THALAMUS LATERAL NUCLEUS; THALAMUS MIDLINE NUCLEUS; THALAMUS VENTRAL NUCLEUS; TUMOR; TUMOR VOLUME;

ANIMALS; BODY COMPOSITION; BODY WEIGHT; DOPAMINE; EATING; HYPOTHALAMUS; MALE; NEOPLASMS, EXPERIMENTAL; NEUROPEPTIDE Y; RATS; RATS, INBRED F344; SEROTONIN;

EID: 3843145203     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2004.03.016     Document Type: Article

References (25)

1. Laviano A., Meguid M.M., Rossi-Fanelli F. Cancer anorexia: clinical implications, pathogenesis and therapeutic strategies. Lancet Oncol. 4:2003;686-694
2. Currie P.J., Coscina D.V. Regional hypothalamic differences in neuropeptide Y-induced feeding and energy substrate utilization. Brain Res. 737:1996;238-242
3. Akabayashi A., Wahlestedt C., Alexander J.T., Leibowitz S.F. Specific inhibition of endogenous neuropeptide Y synthesis in arcuate nucleus by antisense oligonucleotides suppresses feeding behavior and insulin secretion. Mol Brain Res. 21:1994;55-61
4. Shibasaki T., Oda T., Imaki T., Ling N., Demura H. Injection of anti-neuropeptide Y gamma-globulin into the hypothalamic paraventricular nucleus decreases food intake in rats. Brain Res. 601:1993;313-316
5. Erickson J.C., Clegg K.E., Palmiter R.D. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature. 381:1996;415-421
6. Inui A. Cancer anorexia-cachexia syndrome: are neuropeptides the key? Cancer Res. 59:1999;4493-4501
7. Currie P.J., Coscina D.V. Stimulation of 5-HT(2A/2C) receptors within specific hypothalamic nuclei differentially antagonizes NPY-induced feeding. Neuroreport. 8:1997;3759-3762
8. Meguid M.M., Yang Z.J., Laviano A. Meal size and number: relationship to dopamine levels in the ventromedial hypothalamic nucleus. Am J Physiol. 272:1997;R1925-R1930
9. Meguid M.M., Yang Z.J., Koseki M. Eating induced rise in LHA-dopamine correlates with meal size in normal and bulbectomized rats. Brain Res Bull. 36:1995;487-490
10. Meguid M.M., Yang Z.J., Laviano A. Meal size and number: relationship to dopamine levels in the ventromedial hypothalamic nucleus. Am J Physiol. 272:1997;R1925-R1930
11. Sato T., Meguid M.M., Fetissov S.O., Chen C., Zhang L. Hypothalamic dopaminergic receptor expressions in anorexia of tumor-bearing rats. Am J Physiol. 281:2001;R1907-R1916
12. Yang Z.J., Koseki M., Meguid M.M., Gleason J.R., Debonis D. Synergistic effect of rhTNF-alpha and rhIL-1 alpha in inducing anorexia in rats. Am J Physiol. 267:1994;R1056-R1064
13. Turrin NP, Ilyin SE, Gayle D, Plata-Salaman CR, Ramos EJB, Laviano A, et al. Interleukin-1β system in anorectic catabolic tumor bearing rats. Curr Opin Clin Nutr Metab. In press.
14. Meguid M.M., Ramos E.J.B., Laviano A., Varma M., Sato T., Chen C., et al. Tumor anorexia: effects on neuropeptide Y and monoamines in paraventricular nucleus. Peptides. 25:2004;261-266
15. Laviano A., Gleason J.R., Meguid M.M., Yang Z.J., Cangiano C., Fanelli F.R. Effects of intra-VMN mianserin and IL-1ra on meal number in anorectic tumor-bearing rats. J Investig Med. 48:2000;40-48
16. Hartsook E.W., Hershberger T.V. A simplified method for sampling small animal carcasses for analyses. Proc Soc Exp Biol Med. 113:1963;973-977
17. Hoebel B.G., Hernandez L., Schwartz D.H., Mark G.P., Hunter G.A. Microdialysis studies of brain norepinephrine, serotonin, and dopamine release during ingestive behavior. Theoretical and clinical implications. Ann N Y Acad Sci. 575:1989;171-191
18. Tecott L.H., Sun L.M., Akana S.F., Strack A.M., Lowenstein D.H., Dallman M.F., Julius D. Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature. 374:1995;542-546
19. Zhou Q.Y., Palmiter R.D. Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic. Cell. 83:1995;1197-1209
20. Bednar I., Carrer H., Qureshi G.A., Sodersten P. Dopamine D1 or D2 antagonists enhance inhibition of consummatory ingestive behavior by CCK-8. Am J Physiol. 269:1995;R896-R903
21. Aizman O., Brismar H., Uhlen P., Zettergren E., Levey A.I., Forssberg H., et al. Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons. Nat Neurosci. 3:2000;226-230
22. Ng N.K., Lee H.S., Wong P.T. Regulation of striatal dopamine release through 5-HT1 and 5-HT2 receptors. J Neurosci Res. 55:1999;600-607
23. Fetissov S.O., Meguid M.M., Chen C., Miyata G. Synchronized release of dopamine and serotonin in the medial and lateral hypothalamus of rats. Neuroscience. 101:2000;657-663
24. Card J.P., Moore R.Y. Neuropeptide Y localization in the rat suprachiasmatic nucleus and periventricular hypothalamus. Neurosci Lett. 88:1988;241-246
25. Marks D.L., Butler A.A., Turner R., Brookhart G., Cone R.D. Differential role of melanocortin receptor subtypes in cachexia. Endocrinology. 144:2003;1513-1523